Why Is DAVE INC Class A (DAVE) Stock Up Today?

DAVE stock is up 6.53% at $372.30 as of the latest trading session, driven by a recent upgrade from Piper Sandler which initiated coverage with an Overweight rating and a $390 price target. The move comes amid broader analyst activity across the sector, with several firms revising their positions on technology and financial services stocks. The stock’s performance aligns with a recent uptick in sentiment, which has improved from a 30-day average of 56 out of 100 to 63 out of 100 in the last seven days.

What Happened

Piper Sandler’s initiation of coverage with an Overweight rating and a $390 price target marked a significant catalyst for the stock’s rise. The firm’s action followed similar analyst activity, including Evercore ISI Group maintaining an In-Line rating and raising its price target to $350. These developments occurred alongside broader market commentary, including analyst upgrades and downgrades across the tech sector. The stock’s strong performance also reflects its underlying fundamentals, including a 48.6% year-to-date revenue increase and a 34.6% net margin. However, recent insider activity has seen key executives and directors sell shares, including CEO Jason Wilk, CFO Kyle Beilman, and director Preston Dan, all transacting on June 2 and June 4.

What The Data Shows

DAVE is currently trading within its 52-week range of $152.21 to $458.25, having printed 18 fresh 52-week highs on August 27. The stock has a market cap of $4.5 billion and trades at a P/E ratio of 22.4. In the last 90 days, insiders have sold a total of $3.6 million in shares, with no insider purchases recorded. Meanwhile, former President Donald J. Trump disclosed a purchase of $15,001 to $50,000 in DAVE stock on June 4. The stock’s beta of 3.86 indicates high volatility relative to the broader market.

What To Watch

Investors should monitor the stock’s performance against Piper Sandler’s $390 price target and Evercore ISI Group’s revised $350 level. No earnings report is scheduled in the near term, but coverage breadth and analyst revisions will remain key factors to watch.